Comparably Awards

Ocular Therapeutix Claimed Company

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology. read more

EMPLOYEE PARTICIPANTS: 53

TOTAL RATINGS: 988

CEO: Antony Mattessich

HR or Marketing? Claim Your Free Employer Account

Antony Mattessich Ocular Therapeutix CEO Rating

Ocular Therapeutix's CEO, Antony Mattessich, has 58 employee ratings and a score of 94/100, placing them in the Top 5% of similar size companies on Comparably with 51-200 Employees and Top 5% of other companies in Boston. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that females at Ocular Therapeutix rate Antony Mattessich higher than males, giving the CEO a score of 99/100.

Last updated months ago.

Where This Score Ranks Ocular Therapeutix's CEO Rating

TOP
5%
In the Top 5% of 2035 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 270 Nearby Companies in Boston
1st
1st place versus 2 competitors rated on Comparably

May

Jun

Jul

Nov

Jun

A+94 / 100

Jan

Ocular Therapeutix CEO Antony Mattessich Bio

Mr. Antony Mattessich has been the Chief Executive Officer and President of Ocular Therapeutix, Inc. since August 1, 2017. Mr. Mattessich serves as Managing Director of Mundipharma International Limited. He served as Regional Director of Europe Operations at Mundipharma International Limited. He has wealth of experience to Ocular Therapeutix, having held leadership roles for a number of global pharmaceutical companies across the US, Europe and Asia, including Novartis, Bristol Meyers Squibb and Merck & Co. Over the course of his career, Mr. Mattessich has developed expertise across multiple disciplines, including general management, global marketing, new product planning, R&D and business development. Mr. Mattessich was the Managing Director of one of the world's largest privately-owned pharmaceutical companies, Mundipharma. He has been a Director of Ocular Therapeutix, Inc. since June 22, 2017. He holds a Master's Degree in International Affairs from Colombia University and a Bachelor of Arts from University of California, Berkeley.

Who Ranks Ocular Therapeutix's CEO Rating the Highest?

Experience - 3 to 6 Years 100/100

Ethnicity - Asian or Pacific Islander 99/100

Gender - Female 99/100

Who Ranks Ocular Therapeutix's CEO Rating the Lowest?

Department - Operations 89/100

Gender - Male 91/100

Experience - Over 10 Years 94/100

Ocular Therapeutix CEO Antony Mattessich At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Ocular Therapeutix.

Based on 58 ratings, Antony Mattessich ranks right above Biogen's CEO, Michel Vounatsos.

Ocular Therapeutix's CEO is highly regarded by employees with 3 to 6 Years experience, Asian or Pacific Islander employees, and Female employees. However, the Operations department, Male employees, and employees with Over 10 Years experience have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.